Fact CheckerSign in

NCT06598683Completed

tDCS and Spasticity in Stroke Patients

Effects Of Transcranial Direct Current Stimulation On Spasticity In Stroke Patients

Source: ClinicalTrials.gov · Last updated 5 Nov 2026

Brief summary (registry, in English)

Multiple research has worked on tDCS and its impact on stroke. But none have studied the effects of tDCS on stroke in relation to the different stages of stroke like mild, moderate, moderate to severe and severe stroke as per national institute of health (NIH) scale. Additionally, this study will be conducted to address the few drawbacks in previous studies such as short follow up period by employing evidence based standardized protocols. It can potentially instigate the efficacy of tDCS on spasticity, motor recovery and Quality of life in relation to the different severity levels of stroke.

Status (registry)
Completed
Study type
Interventional
Enrollment
55 (actual)
First submitted
12 Sept 2024
Start date
1 Oct 2024
Primary completion date
30 Jul 2025
Lead sponsor
Riphah International University
Diseases
Stroke
NCT number
NCT06598683

What you commit to

  • Study type: Interventional
  • Participants enrolled: 55
  • From 1 Oct 2024 to the primary completion date, 30 Jul 2025
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Have any metallic implant including intracranial electrode, pacemaker, surgical clip.

Other illness

  • Any neurological disorder

Other

  • Any symptoms effecting understanding of instructions.

Who the study is looking for

  • Stroke for more than 6 months.
  • Both genders.
  • Spasticity score ≥1 at modified ashworth scale.
  • National Institutes of Health Stroke Scale (NIHSS) for severity level; Mild (1-4), Moderate (5-15), Moderate to Severe (16-20), Severe (21-42)

Age in the registry: 30 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Pakistan Railway General Hospital
Coordinator of this site? Confirm its status
RawalpindiPakistanUnknown status
Pakistan Railway Hospital
Coordinator of this site? Confirm its status
RawalpindiPakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.